Literature DB >> 11022088

Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab.

R T Cheung, D S Ho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022088     DOI: 10.1161/01.str.31.10.2517-a

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

Review 1.  Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.

Authors:  Pitchaiah Mandava; Perumal Thiagarajan; Thomas A Kent
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke.

Authors:  Salvatore Mangiafico; Martino Cellerini; Patrizia Nencini; Gianfranco Gensini; Domenico Inzitari
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Postoperative intracranial thrombolysis and angioplasty.

Authors:  O Levrier; J M Stordeur; N Bruder; L Manera; P Bouillot; C H Raybaud
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

4.  A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice.

Authors:  Pitchaiah Mandava; William Dalmeida; Jane A Anderson; Perumal Thiagarajan; Roderic H Fabian; Raymond U Weir; Thomas A Kent
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 5.  Oral antiplatelet therapy for acute ischaemic stroke.

Authors:  Peter A G Sandercock; Carl Counsell; Mei-Chiun Tseng; Emanuela Cecconi
Journal:  Cochrane Database Syst Rev       Date:  2014-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.